Predian in the complex treatment of patients with diabetes mellitus
I. V. Grigorieva
Kazan medical journal ›› 1988, Vol. 69 ›› Issue (4) : 295 -296.
Predian in the complex treatment of patients with diabetes mellitus
The aim of this work was to study the effectiveness of predian (sulfonamide developed at the Research Institute Servier, France) as a sugar-lowering agent, as well as its effect on the coagulation and antiplatelet systems of diabetic patients.
Eco-Vector
/
| 〈 |
|
〉 |
PDF
